Using the common sense model to understand perceived cancer risk in individuals testing for BRCA 1/2 mutations

Psycho-Oncology

Volumn 14, Issue 1, 2005, Pages 34-48

  Kelly, Kimberly ^a   Leventhal, Howard ^b   Andrykowski, Michael ^a   Toppmeyer, Deborah ^c   Much, Judy ^c   Dermody, James ^d   Marvin, Monica ^e   Baran, Jill ^d   Schwalb, Marvin ^d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

^e SPECTRUM HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ANAMNESIS; ARTICLE; BREAST CANCER; CANCER CONTROL; CANCER RISK; CANCER SURGERY; CLASSIFICATION; CONTROLLED STUDY; EXPERIENCE; FAMILY HISTORY; FEMALE; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; OVARY CANCER; PATIENT COUNSELING; PERCEPTION; RISK ASSESSMENT; RISK REDUCTION; STATISTICAL MODEL; SYMPTOMATOLOGY; TIME;

ANALYSIS OF VARIANCE; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; JEWS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 12344282016     PISSN: 10579249     EISSN: None     Source Type: Journal    
DOI: 10.1002/pon.805     Document Type: Article

References (35)

1. Bastian LA, Lipkus IM, Kuchibhatla MN, Weng HH, Halabi S, Ryan PD. 2001. Women's interest in chemoprevention for breast cancer. Arch Intern Med 13: 1639-1644.
2. Baty BJ, Venne VL, McDonald J et al. 1997. BRCA1 testing: Genetic counseling protocol development and counseling issues. J Genet Couns 6(2): 223-244.
3. Berry DA, Parmigiani G. 1997. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 89(21): 16-34.
4. Bish A, Sutton S, Jacobs C, Levene S, Ramirez A, Hodgson S. 2002. Changes in psychological distress after cancer genetic counselling: A comparison of affected and unaffected women. Br J Cancer 86 43-50.
5. Bluman LG, Rimer BK, Berry DA et al. 1999. Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. J Clin Oncol 17 3): 1040-1046.
6. Burke W, Culver JO, Bowen D et al. 2000. Genetic counseling for women with an intermediate family history of breast cancer. Am J Med Genet 90: 361-368.
7. Cull A, Anderson EDC, Campbell S, Mackay J, Smyth E, Steel M. 1999. The impact of genetic counselling about breast cancer risk on women's risk perceptions and levels of distress. Br J Cancer 79 3/4): 501-508.
8. Decruyenaere M, Evers-Kiebooms G, Welkenhuysen M, Denayer L, Claes E. 2000. Cognitive representations of breast cancer, emotional distress and preventive health behavior: A theoretical perspective. Psychooncology 9: 528-536.
9. Evans DGR, Blair V, Greenhalgh R, Hopwood P, Howell A. 1994. The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br J Cancer 70: 934-938.
10. Hopwood P, Keeling F, Long A, Pool C, Evans G, Howell A. 1998. Psychological support needs for women at high genetic risk of breast cancer: Some preliminary indicators. Psycho-oncology 7 402-412.
11. Hurley KE, Miller SM, Costalas JW, Gillespie D, Daly M. 2001. Anxiety/uncertainty reduction as a motivation for interest in prophylactic oophorectomy in women with a family history of ovarian cancer. J Womens Health Gen Based Med 10(2): 189-199.
12. Kelly K, Leventhal H, Toppmeyer D et al. 2003. Subjective and objective risk of carrying a BRCA1/2 mutation in individuals of Ashkenazi Jewish descent. J Genet Couns 12(4): 351-371.
13. Lau RR, Hartman KA. 1983. Common sense representations of common illnesses. Health Psychol 2: 167-185.
14. Lerman C, Biesecker BB, Benkendorf JL et al. 1997. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 Gene Testing. J Natl Cancer Inst 89 2): 148-157.
15. Lerman C, Hughes C, Croyle RT et al. 2000. Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Prev Med 31: 75-80.
16. Leventhal H, Benyamini Y, Brownlee S et al. 1997. Illness representation: Theoretical foundations. In: Perceptions of Health and Illness, Weinman J, Petrie K (eds). Harwood Publishers: London; 19-45.
17. Leventhal H, Diefenbach MA, Leventhal EA. 1992. Illness cognition: Using common sense to understand treatment adherence and affect cognition interactions. Cogn Ther Res 16: 143-163.
18. Lipkus IM, Crawford Y, Fenn K et al. 1999. Testing different formats for communicating colorectal cancer risk. J Health Commun 4: 311-324.
19. Lipkus IM, Kuchibhatla M, McBride CM et al. 2000. Relationships among breast cancer perceived absolute risk, comparative risk, and worries. Cancer Epidemiol Biomarkers Prev 9: 973-975.
20. Lippman-Hand A, Fraser FC. 1979. Genetic counseling: Provision and reception of information. Am J Med Genet 3: 113-127.
21. Meiser B, Halliday JL. 2002. What is the impact of genetic counselling in women at increased risk of developing hereditary breast cancer? A meta-analytic review. Soc Sci Med 54: 1463-1470.
22. National Society of Genetic Counselors. 2003. www.nsgc.org [Web Page].
23. Norem JK, Cantor N. 1986. Defensive pessimism: Harnessing anxiety as motivation. J Pers Soc Psychol 51(6): 1208-1217.
24. Parmigiani G, Berry DA, Aguilar O. 1998. Modeling risk of breast cancer and decisions about genetic testing. Am J Hum Genet 62: 145-148.
25. Schwartz MD, Peshkin BN, Hughes C, Main D, Isaacs C, Lerman C. 2002. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. J Clin Oncol 20(2): 514-520.
26. Schwartz LM, Woloshin S, Black WC, Welch HG. 1997. The role of numeracy in understanding the benefit of screening mammography. Ann Intern Med 127(11): 966-972.
27. Sheridan SL, Pignone, M. 2002. Numeracy and the medical student's ability to interpret data. Eff Clin Pract 5: 35-40.
28. Shiloh S, Berkenstadt M. 1992. Lay conceptions of genetic disorders. Birth Defects Orig Artic Ser 28(1): 191-200.
29. Struewing JP, Hartge P, Wacholder S et al. 1997. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 336(20): 1401-1408.
30. Tonin P, Weber B, Offit K et al. 1996. Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families. Nat Med 2(11): 1179-1183.
31. Tversky A, Kahneman D. 1974. Judgement under uncertainty: Heuristics and biases. Science 185: 1124-1131.
32. Watson M, Lloyd S, Davidson J et al. 1999. The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. Br J Cancer 79(5/6): 868-874.
33. Weinman J, Petrie KJ, Moss-Morris R, Horne R. 1996. The illness perception questionnaire: A new method for assessing the cognitive representation of illness. Psychol Health 11(3): 431-445.
34. Weinstein N. 1984. Why it won't happen to me: Perceptions of risk factors and susceptibility. Health Psychol 3(5): 431-457.
35. Woloshin S, Schwartz LM, Moncur M, Gabriel S, Tosteson ANA. 2001. Assessing values for health: Numeracy matters. Med Decis Making 21: 382-390.